Hopefully this was the calm before the storm and assays surprise the market next week and we move up from here. I noticed that RBC has an analyst on this and they lowered their 12 month guidance from $1.25 to $1.00. (The funny thing is that RBC was the biggest buyer for the week at 384k shares.) I am OK with that target as that is still up 100% from where we are now. With an EPS estimate of 9 cents for 2012, the $1.00 mark is probably fair based on earnings only. However, if we get significant development at Marmato during 2012, I think we should easily be over that target.
Glorieux